{"id":57248,"date":"2020-01-16T07:26:08","date_gmt":"2020-01-16T07:26:08","guid":{"rendered":"https:\/\/www.alj.com\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/"},"modified":"2020-03-19T11:15:58","modified_gmt":"2020-03-19T11:15:58","slug":"abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets","status":"publish","type":"news","link":"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/","title":{"rendered":"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo."},"content":{"rendered":"<ul>\n<li>El objetivo es proporcionar an\u00e1lisis de sangre sencillos, precisos, asequibles y r\u00e1pidos a los pa\u00edses en desarrollo.<\/li>\n<li>Dispositivo PoCT (an\u00e1lisis en el punto de atenci\u00f3n) de \u00faltima generaci\u00f3n que permite realizar m\u00faltiples par\u00e1metros de an\u00e1lisis de sangre de forma simult\u00e1nea.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/alj-japan.co.jp\/english\/japan\/\">Abdul Latif Jameel General Trading<\/a> con sede en Tokio Jap\u00f3n, parte del negocio familiar diversificado <a href=\"https:\/\/alj.com\">Abdul Latif Jameel<\/a>, anunci\u00f3 una nueva colaboraci\u00f3n con <a href=\"https:\/\/cellspect.com\/en\/\">Cellspect<\/a> para la distribuci\u00f3n del dispositivo de an\u00e1lisis de sangre Cellspect en Oriente Medio, \u00c1frica, Sureste de Asia e India.<\/p>\n<p>Cellspect, con sede en Jap\u00f3n, desarrolla y produce dispositivos PoCT (o de an\u00e1lisis en el punto de atenci\u00f3n) de nueva generaci\u00f3n que permiten seleccionar simult\u00e1neamente m\u00faltiples par\u00e1metros de an\u00e1lisis de sangre. Las pruebas bioqu\u00edmicas b\u00e1sicas como \u201cmetabolismo del az\u00facar\u201d , \u201cl\u00edpidos\u201d y \u201cfunci\u00f3n hep\u00e1tica\u201d pueden medirse f\u00e1cilmente con solo una gota de sangre del dedo del paciente, y el propio dispositivo, en un formato sencillo de usar, compacto y port\u00e1til para facilitar su despliegue y uso en \u00e1reas remotas y entornos rurales.<\/p>\n<p>Este dispositivo de bajo coste proporciona resultados en menos de 5 minutos, lo que lo hace extremadamente r\u00e1pido, competitivo en cuanto a costes y accesible para las poblaciones de los pa\u00edses en desarrollo, en comparaci\u00f3n con muchos dispositivos PoCT existentes.<\/p>\n<p><iframe loading=\"lazy\" title=\"Abdul Latif Jameel &amp;  Cellspect Announce Collaboration (EN 16:9)\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/RaydkfoEsPU?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Adem\u00e1s de los par\u00e1metros de an\u00e1lisis de sangre existentes, que han demostrado tener niveles de precisi\u00f3n muy altos, Cellspect tambi\u00e9n tiene previsto a\u00f1adir otros m\u00faltiples par\u00e1metros en un futuro pr\u00f3ximo, incluyendo marcadores card\u00edacos, marcadores de c\u00e1ncer, virus y alergias, por nombrar algunos, con el objetivo de tener m\u00e1s de 35 par\u00e1metros de an\u00e1lisis de sangre en un \u00fanico y sencillo dispositivo.<\/p>\n<p>En previsi\u00f3n de la continua expansi\u00f3n internacional, Cellspect tambi\u00e9n podr\u00e1 personalizar los par\u00e1metros y objetivos de los an\u00e1lisis para satisfacer las necesidades inmediatas de cada pa\u00eds.<\/p>\n<p>A trav\u00e9s de esta alianza, Abdul Latif Jameel General Trading y Cellspect aspiran a crear oportunidades accesibles y asequibles, en especial en las regiones en desarrollo, proporcionando verificaciones de salud de an\u00e1lisis de sangre a poblaciones que tal vez no tengan un acceso c\u00f3modo o asequible a las instalaciones sanitarias.<\/p>\n<p>Abdul Latif Jameel cree que la creaci\u00f3n de una capacidad de an\u00e1lisis de sangre c\u00f3moda, asequible, r\u00e1pida y precisa puede contribuir en gran medida para mejorar la infraestructura m\u00e9dica y la atenci\u00f3n sanitaria personal en los pa\u00edses en desarrollo y ayudar en las iniciativas para la detecci\u00f3n temprana y prevenci\u00f3n de enfermedades.<\/p>\n<p>A trav\u00e9s de la inversi\u00f3n en las tecnolog\u00edas m\u00e9dicas superiores del Jap\u00f3n y el apoyo empresarial para el desarrollo de tecnolog\u00edas m\u00e9dicas innovadoras del Jap\u00f3n en los pa\u00edses emergentes, Abdul Latif Jameel General Trading se esfuerza por seguir haciendo una contribuci\u00f3n social significativa.<\/p>\n","protected":false},"featured_media":56780,"template":"","tags":[],"newscategory":[149],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Colaboraci\u00f3n para un dispositivo de an\u00e1lisis de sangre de bajo coste | Abdul Latif Jameel\u00ae<\/title>\n<meta name=\"description\" content=\"Abdul Latif Jameel y Cellspect anuncian una nueva colaboraci\u00f3n para la distribuci\u00f3n del dispositivo de an\u00e1lisis de sangre en Oriente Medio, \u00c1frica, Sudeste Asi\u00e1tico e India.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Colaboraci\u00f3n para un dispositivo de an\u00e1lisis de sangre de bajo coste | Abdul Latif Jameel\u00ae\" \/>\n<meta property=\"og:description\" content=\"Abdul Latif Jameel y Cellspect anuncian una nueva colaboraci\u00f3n para la distribuci\u00f3n del dispositivo de an\u00e1lisis de sangre en Oriente Medio, \u00c1frica, Sudeste Asi\u00e1tico e India.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/\" \/>\n<meta property=\"og:site_name\" content=\"Abdul Latif Jameel\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Abdul.Latif.Jameel.Official\" \/>\n<meta property=\"article:modified_time\" content=\"2020-03-19T11:15:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/media.alj.com\/app\/uploads\/2020\/01\/Cellspect-signing.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1235\" \/>\n\t<meta property=\"og:image:height\" content=\"922\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/\",\"url\":\"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/\",\"name\":\"Colaboraci\u00f3n para un dispositivo de an\u00e1lisis de sangre de bajo coste | Abdul Latif Jameel\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/alj.com\/en\/#website\"},\"datePublished\":\"2020-01-16T07:26:08+00:00\",\"dateModified\":\"2020-03-19T11:15:58+00:00\",\"description\":\"Abdul Latif Jameel y Cellspect anuncian una nueva colaboraci\u00f3n para la distribuci\u00f3n del dispositivo de an\u00e1lisis de sangre en Oriente Medio, \u00c1frica, Sudeste Asi\u00e1tico e India.\",\"breadcrumb\":{\"@id\":\"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/alj.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/alj.com\/en\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/alj.com\/en\/#website\",\"url\":\"https:\/\/alj.com\/en\/\",\"name\":\"Abdul Latif Jameel\",\"description\":\"Abdul Latif Jameel\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/alj.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es-ES\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Colaboraci\u00f3n para un dispositivo de an\u00e1lisis de sangre de bajo coste | Abdul Latif Jameel\u00ae","description":"Abdul Latif Jameel y Cellspect anuncian una nueva colaboraci\u00f3n para la distribuci\u00f3n del dispositivo de an\u00e1lisis de sangre en Oriente Medio, \u00c1frica, Sudeste Asi\u00e1tico e India.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/","og_locale":"es_ES","og_type":"article","og_title":"Colaboraci\u00f3n para un dispositivo de an\u00e1lisis de sangre de bajo coste | Abdul Latif Jameel\u00ae","og_description":"Abdul Latif Jameel y Cellspect anuncian una nueva colaboraci\u00f3n para la distribuci\u00f3n del dispositivo de an\u00e1lisis de sangre en Oriente Medio, \u00c1frica, Sudeste Asi\u00e1tico e India.","og_url":"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/","og_site_name":"Abdul Latif Jameel","article_publisher":"https:\/\/www.facebook.com\/Abdul.Latif.Jameel.Official","article_modified_time":"2020-03-19T11:15:58+00:00","og_image":[{"width":1235,"height":922,"url":"https:\/\/media.alj.com\/app\/uploads\/2020\/01\/Cellspect-signing.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/","url":"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/","name":"Colaboraci\u00f3n para un dispositivo de an\u00e1lisis de sangre de bajo coste | Abdul Latif Jameel\u00ae","isPartOf":{"@id":"https:\/\/alj.com\/en\/#website"},"datePublished":"2020-01-16T07:26:08+00:00","dateModified":"2020-03-19T11:15:58+00:00","description":"Abdul Latif Jameel y Cellspect anuncian una nueva colaboraci\u00f3n para la distribuci\u00f3n del dispositivo de an\u00e1lisis de sangre en Oriente Medio, \u00c1frica, Sudeste Asi\u00e1tico e India.","breadcrumb":{"@id":"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/alj.com\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/alj.com\/es\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/alj.com\/en\/news\/"},{"@type":"ListItem","position":3,"name":"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo."}]},{"@type":"WebSite","@id":"https:\/\/alj.com\/en\/#website","url":"https:\/\/alj.com\/en\/","name":"Abdul Latif Jameel","description":"Abdul Latif Jameel","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/alj.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es-ES"}]}},"post-meta-fields":{"_alp_processed":["1580116130"],"_wpml_word_count":["{\"total\":450,\"to_translate\":{\"ar\":450,\"zh-hans\":450,\"fr\":450,\"ja\":450,\"es\":450,\"tr\":450}}"],"push_notification":["no"],"_push_notification":["field_5c3b1fb67034d"],"_wpml_media_featured":["1"],"_wpml_media_duplicate":["1"],"news_slider_short_title":["Dispositivos de an\u00e1lisis de sangre para mercados emergentes"],"news_summary":["<p>El objetivo es proporcionar an\u00e1lisis de sangre sencillos, precisos, asequibles y r\u00e1pidos a los pa\u00edses en desarrollo.<\/p>\n"],"news-location":["Tokio, Jap\u00f3n"],"wpcf-featured-news":["0"],"publish_mobile":[""],"_publish_mobile":["field_5bfa8eb2e65cf"],"mobile_featured_image":["https:\/\/media.alj.com\/app\/uploads\/2020\/01\/Cellspect-signing.jpg"],"_mobile_featured_image":["field_5c3b204983dea"],"_yoast_wpseo_primary_newscategory":["149"],"_wpcf-card-image-sort-order":["a:1:{i:0;i:672239;}"],"_yoast_wpseo_content_score":["30"],"post_views_count_2020Jan":["65"],"_oembed_bfc42cce9e9884eed479208c70d9ace1":["<iframe title=\"Abdul Latif Jameel and Cellspect announce new healthtech collaboration  (EN 16:9)\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/oMvFnbFeiEM?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen><\/iframe>"],"_oembed_time_bfc42cce9e9884eed479208c70d9ace1":["1579779622"],"_oembed_3f9fd226e955e13298791978314ec2ad":["<iframe title=\"Abdul Latif Jameel and Cellspect announce new healthtech collaboration  (EN 16:9)\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/oMvFnbFeiEM?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen><\/iframe>"],"_oembed_time_3f9fd226e955e13298791978314ec2ad":["1579779626"],"_oembed_29a5046e0be1d70e0aa4e909a715a5d3":["<iframe title=\"Abdul Latif Jameel &amp;  Cellspect Announce Collaboration (EN 16:9)\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/RaydkfoEsPU?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen><\/iframe>"],"_oembed_time_29a5046e0be1d70e0aa4e909a715a5d3":["1584616590"],"_thumbnail_id":["56780"],"_last_translation_edit_mode":["native-editor"],"post_views_count_2020Feb":["20"],"post_views_count_2020Mar":["30"],"news_business_sector":["Corporativa"],"wpcf-show-at-homepage-first-sec-secondary-slider":["1"],"wpcf-card-image":[""],"wpcf-news-publish_date":["1574640000"],"_yoast_wpseo_title":["Colaboraci\u00f3n para un dispositivo de an\u00e1lisis de sangre de bajo coste | Abdul Latif Jameel\u00ae"],"_yoast_wpseo_metadesc":["Abdul Latif Jameel y Cellspect anuncian una nueva colaboraci\u00f3n para la distribuci\u00f3n del dispositivo de an\u00e1lisis de sangre en Oriente Medio, \u00c1frica, Sudeste Asi\u00e1tico e India."],"post_views_count_2020Apr":["25"],"post_views_count_2020May":["23"],"post_views_count_2020Jun":["28"],"post_views_count_2020Jul":["28"],"post_views_count_2020Aug":["15"],"post_views_count_2020Sep":["16"],"post_views_count_2020Oct":["27"],"post_views_count_2020Nov":["18"],"post_views_count_2020Dec":["11"],"post_views_count_2021Jan":["24"],"post_views_count_2021Feb":["24"],"post_views_count_2021Mar":["23"],"post_views_count_2021Apr":["19"],"post_views_count_2021May":["15"],"post_views_count_2021Jun":["4"],"post_views_count_2021Jul":["9"],"post_views_total_count":["9"]},"_links":{"self":[{"href":"https:\/\/alj.com\/es\/wp-json\/wp\/v2\/news\/57248"}],"collection":[{"href":"https:\/\/alj.com\/es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/alj.com\/es\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alj.com\/es\/wp-json\/wp\/v2\/media\/56780"}],"wp:attachment":[{"href":"https:\/\/alj.com\/es\/wp-json\/wp\/v2\/media?parent=57248"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alj.com\/es\/wp-json\/wp\/v2\/tags?post=57248"},{"taxonomy":"newscategory","embeddable":true,"href":"https:\/\/alj.com\/es\/wp-json\/wp\/v2\/newscategory?post=57248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}